Medical News by Xagena

23 aprile 2018 tiberis1 Biomedicina

MedicineNews.net: Drugs – Medicine News

Newsletter :: Medicine, Aggiornamenti in Medicina, Newsletter :: Medicina, Newsletter :: Medical News, Medicine News, Medicine Newsletter, MedicineNews.net, AZ Guide Medicine, Newsletter Allergology, Newsletter Andrology, Newsletter Cardiology, Newsletter Dermatology, Newsletter Diabetology, Xagena Medical News, Newsletter Hematology, Newsletter Oncology,

–

Cimzia The Food and Drug Administration ( FDA ) has approved Cimzia …	Rivaroxaban The oral anticoagulant Xarelto ( Rivaroxaban ) has been …
Dapagliflozin Forxiga ( Dapagliflozin ) is the first SGLT2 ( sodium/glucose …	Sirturo Treatment for drug-resistant tuberculosis: Sirturo shows …
Teriflunomide Teriflunomide ( Aubagio ) is an immunomodulatory drug …	Potiga The FDA ( Food and Drug Administration ) has approved …
Macitentan The Food and Drug Administration ( FDA ) has approved Opsumit …	Opsumit The Food and Drug Administration ( FDA ) has approved Opsumit …
Forxiga Forxiga, a SGLT2 inhibitor, approved in Europe for …	Pertuzumab Pertuzumab for the treatment of patients with HER2-positive …

Aggiornamenti in Medicina, AZ Guide Medicine, Informazioni in Medicina, Informazioni mediche, Medical News :: Medicine Updates, Medical News by Xagena, Medicamenti, Medicina, Medicinali, Medicinali Newsletter, Medicine, Medicine News, Medicine Newsletter, MedicineNews.net, Newsletter :: Medical News, Newsletter Allergology, Newsletter Andrology, Newsletter Cardiology, Newsletter Dermatology, Newsletter Diabetology, Newsletter Hematology, Newsletter Medicina, Newsletter Medicine, Newsletter Oncology, Xagena Medical News

Novità sui Farmaci by Xagena

23 aprile 2018 tiberis1 Biomedicina

Farmaci – FarmaciOnline.it News

Newsletter Farmacologia, Le Novità in Farmacologia, Farmaci Novità, Farmaci Newsletter, Farmaci News, FarmaciOnline.it, Newsletter :: Terapia farmacologica, Aggiornamento sui Farmaci, Farmaci per il cuore :: Novità, Farmaci per la pelle :: Novità, Farmaci per il sistema nervoso :: Novità, Farmaci per i tumori :: Novità, Reazioni avverse ai farmaci Newsletter, Newsletter Reazioni avverse ai farmaci, Newsletter Corretto impiego ai Farmaci,

–

FDA ha approvato Velcade per … FDA ha approvato Velcade per il ritrattamento del mieloma …	Sclerosi multipla: la … Sclerosi multipla: la Commissione europea ha approvato …
Malattia di Alzheimer L’FDA ha approvato Aricept 23 mg nel trattamento della malattia di …	Malattia renale cronica … Mircera nel trattamento dell’anemia nei pazienti con malattia …
Sclerosi multipla recidivante … Sclerosi multipla recidivante-remittente: l’FDA ha approvato …	Ipertensione arteriosa … Opsumit nel trattamento della ipertensione arteriosa …
FDA ha approvato Nexavar … FDA ha approvato Nexavar per il … con carcinoma differenziato …	Carcinoma epatocellulare L’FDA ha approvato Nexavar nei pazienti con carcinoma …
Leucemia mieloide cronica Imatinib , trattamento di prima scelta della leucemia mieloide …	Edema maculare Commissione Europea: Lucentis per il trattamento del edema …

Aggiornamenti sui Farmaci, Aggiornamento sui Farmaci, Farmaci, Farmaci :: Novità, Farmaci News, Farmaci Newsletter, Farmaci per i tumori :: Novità, Farmaci per il cuore :: Novità, Farmaci per il sistema nervoso :: Novità, Farmaci per la pelle :: Novità, FarmaciOnline.it, Informazioni sui Farmaci, Le Novità in Farmacologia, Medicinali, Medicine, Newsletter :: Terapia farmacologica, Newsletter Corretto impiego ai Farmaci, Newsletter Farmacologia, Newsletter Reazioni avverse ai farmaci, Novità sui Farmaci by Xagena, Nutraceutici, Reazioni avverse ai farmaci Newsletter

Pharmacological Therapy by Xagena

22 aprile 2018 tiberis1 Biomedicina

Drugs News – DrugsNews.net

Drugs, DrugsNews.net, Drugs Newsletter, Drugs Updates, Drugs News, EBM :: Evidence-based Medicine, Cardiology Updates, Oncology Updates, Hematology Updates, Nephrology Updates, Dermatology Updates, Neurology Updates, Rheumatology Updates, Cancer Therapy Newsletter, Immune checkpoint inhibitors to treat cancer, American Cancer Society Report, Checkpoint blocking antibodies in cancer immunotherapy, Checkpoint blockade in cancer immunotherapy – Updates,

DrugsNews.net – Drugs Xagena ×Close. DrugsNews.net. Drugs Xagena. Newsletter Xagena …	Avandia Avandia ( Rosiglitazone ) is a member of the thiazolidinedione …
Metastatic colorectal cancer It is used to treat metastatic colorectal cancer in adults who …	Cosentyx IL-17 inhibitors: Cosentyx for first-line treatment of moderate-to …
Drugs Xagena Afinitor in advanced renal cell carcinoma after failure of …	Immuno-oncology therapy Immuno-oncology therapy: Opdivo for the treatment of patients with …
Enoxaparin Edoxaban versus Enoxaparin in preventing venous …	Ibrance Er+ and HER2- advanced breast cancer: FDA approves Ibrance …
Edoxaban Edoxaban versus Enoxaparin in preventing venous …	Actos Long-term treatment with Actos: increased incidence of …
Altri risultati in drugsnews.net »

American Cancer Society Report, Cancer Therapy Newsletter, Cardiology Updates, Checkpoint blockade in cancer immunotherapy - Updates, Checkpoint blocking antibodies in cancer immunotherapy, Dermatology Updates, Drugs, Drugs News, Drugs Newsletter, Drugs Updates, DrugsNews.net, EBM :: Evidence-based Medicine, Farmaci, Farmacia, Farmacologia, Hematology Updates, Immune checkpoint inhibitors to treat cancer, Medicinali, Medicine, Nephrology Updates, Neurology :: Updates, Oncology Updates, Pharmacological Therapy by Xagena, Rheumatology Updates

« 1 2 3

Aggiornamenti in Medicina e Malattie rare

Tag: Medicinali